RxDoctor Payments Data

Nicholas Wilcox, MD

Sports Medicine · Marysville, WANPI 1497102651

Payments from drug & device makers

What this record shows

This record is dominated by grants: $35,000 of the $36,276 with a category attached, or 96.5%. 6 manufacturers reported payments, led by Medtronic at 55.1% of the total. Among sports medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,276in general payments, 2019–2025

Across 7 payments — averaging $5182.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$20K
  • Saol Therapeutics Inc.$15K
  • Pylant Medical$1K
  • AbbVie$32
  • Abbott$24
  • Hydrocision, Inc.$20

What the payments were for

  • Grants$35,00096%
  • Food & beverage$760%
  • Education$1,2003%

General payments by program year

20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic1$20,000
Saol Therapeutics Inc.1$15,000
Pylant Medical1$1,200
AbbVie2$32
Abbott1$24
Hydrocision, Inc.1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,276 in reported general payments places this provider in the 95th percentile of 132 sports medicine providers in Washington.

See all sports medicine providers in Washington

Medicare billing

Part B allowed, 2024
$67,218
Medicare patients
203
Services billed
1,530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib49$740
Methylprednisolone39$349
Diclofenac Sodium11$124
Meloxicam31$38

Paid to pharmacies, not to this prescriber.

Other sports medicine in Marysville

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →